Slowing the progression of Alzheimer's disease; what works?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Ageing Research Reviews

• Publication date

  2015-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.arr.2015.07.002PMID 26219494
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cognitive reserve.

  2020cited by this paper
• Serum 25‐hydroxyvitamin D level and the risk of mild cognitive impairment and dementia: the Korean Longitudinal Study on Health and Aging (KLoSHA)

  2015cited by this paper
• Aerobic exercise to improve cognitive function in older people without known cognitive impairment.

  2015cited by this paper
• Amelioration of Osteoporosis and Hypovitaminosis D by Sunlight Exposure in Hospitalized Elderly Women With Alzheimer's Disease: A Randomized Controlled Trial

  2015cited by this paper
• Observational and Ecological Studies of Dietary Advanced Glycation End Products in National Diets and Alzheimer's Disease Incidence and Prevalence

  2015cited by this paper
• Questioning vitamin D status of elderly fallers and nonfallers: a meta‐analysis to address a ‘forgotten step’

  2015cited by this paper
• Longitudinal relationships between Alzheimer disease progression and psychosis, depressed mood, and agitation/aggression.

  2015cited by this paper
• Immunotherapeutic approaches for Alzheimer's disease.

  2015cited by this paper
• Amyloid imaging with [18F]florbetapir in geriatric depression: early‐onset versus late‐onset

  2015cited by this paper
• Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

  2014cited by this paper
• Effect of advanced glycation end product intake on inflammation and aging: a systematic review.

  2014cited by this paper
• Vitamin D and the risk of dementia and Alzheimer disease

  2014cited by this paper
• Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward

  2014cited by this paper
• Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches

  2014cited by this paper
• Body Weight, Eating Patterns, and Physical Activity: The Role of Education

  2014cited by this paper
• Cognitive and neural signatures of the APOE E4 allele in mid-aged adults

  2014cited by this paper
• Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

  2014cited by this paper
• 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

  2014cited by this paper
• Error-monitoring in an everyday task in people with Alzheimer-type dementia: Observations over five years of performance decline

  2014cited by this paper
• Dietary advanced glycation end products are associated with decline in memory in young elderly.

  2014cited by this paper
• Hypertension and Inflammation in Alzheimer's Disease: Close Partners in Disease Development and Progression!

  2014cited by this paper
• Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.

  2014cited by this paper
• Maintenance cognitive stimulation therapy for dementia: single-blind, multicentre, pragmatic randomised controlled trial

  2014cited by this paper
• Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans

  2014cited by this paper
• Serum homocysteine levels are correlated with behavioral and psychological symptoms of Alzheimer’s disease

  2014cited by this paper
• Correlation between Behavioural and Psychological Symptoms of Alzheimer Type Dementia and Plasma Homocysteine Concentration

  2014cited by this paper
• Clinical trials and late‐stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

  2014cited by this paper
• Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.

  2014cited by this paper
• Reduced 25‐hydroxyvitamin D and risk of Alzheimer's disease and vascular dementia

  2014cited by this paper
• Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study.

  2014influential reference
• Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: a systematic review.

  2014cited by this paper
• Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer's disease-experimental approach and therapeutic implications

  2014cited by this paper
• Suppression of native defense mechanisms, SIRT1 and PPARγ, by dietary glycoxidants precedes disease in adult humans; relevance to lifestyle-engendered chronic diseases

  2014cited by this paper
• Vitamin D supplementation restores suppressed synaptic plasticity in Alzheimer's disease

  2014cited by this paper
• Reversal of cognitive decline: A novel therapeutic program

  2014cited by this paper
• Blood pressure variability predicts cognitive decline in Alzheimer's disease patients.

  2014cited by this paper
• Resveratrol levels and all-cause mortality in older community-dwelling adults.

  2014cited by this paper
• Targeting the β secretase BACE1 for Alzheimer's disease therapy.

  2014cited by this paper
• Which factors are associated with mortality in institutionalized older adults with dementia?

  2014cited by this paper
• The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer’s Disease: A Randomised Controlled Study

  2014cited by this paper
• Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities.

  2014cited by this paper
• O4–05–05: Consistency of BACE inhibitor‐mediated brain amyloid production inhibition by MK‐8931 in Alzheimer's disease patients and healthy young adults

  2013cited by this paper
• Retracted: Aging is associated with altered inflammatory, arachidonic acid cascade, and synaptic markers, influenced by epigenetic modifications, in the human frontal cortex

  2013cited by this paper
• Hypotensive Syndromes Are Not Associated With Cognitive Impairment in Geriatric Patients

  2013cited by this paper
• Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.

  2013cited by this paper
• Inflammatory Proteins in Plasma Are Associated with Severity of Alzheimer’s Disease

  2013cited by this paper
• Exposure to ultraviolet-B and risk of developing rheumatoid arthritis among women in the Nurses’ Health Study

  2013cited by this paper
• Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer’s disease: analysis of effects of baseline features on treatment response

  2013cited by this paper
• P4–412: Effect of memantine on the progression of driving impairment in mild Alzheimer's disease

  2013cited by this paper
• Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway.

  2013cited by this paper
• The effect of exercise interventions on cognitive outcome in Alzheimer's disease: a systematic review

  2013influential reference
• Curcumin protects organotypic hippocampal slice cultures from Aβ1-42-induced synaptic toxicity.

  2013cited by this paper
• Physical Exercise and Brain Functions in Older Adults

  2013cited by this paper
• Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence

  2013cited by this paper
• Microglia and neurodegeneration: The role of systemic inflammation

  2013cited by this paper
• Review: Microglia of the aged brain: primed to be activated and resistant to regulation

  2013cited by this paper
• Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease

  2013cited by this paper
• Optimal Blood Pressure for Cognitive Function: Findings from an Elderly African‐American Cohort Study

  2013cited by this paper
• Meta-Regression Analyses, Meta-Analyses, and Trial Sequential Analyses of the Effects of Supplementation with Beta-Carotene, Vitamin A, and Vitamin E Singly or in Different Combinations on All-Cause Mortality: Do We Have Evidence for Lack of Harm?

  2013cited by this paper
• Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.

  2013cited by this paper
• Cognitive training and cognitive rehabilitation for persons with mild to moderate dementia of the Alzheimer's or vascular type: a review

  2013influential reference
• The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease

  2013cited by this paper
• Tauopathies and Tau Oligomers

  2013cited by this paper
• Relationship of Cognitive Function with B Vitamin Status, Homocysteine, and Tissue Factor Pathway Inhibitor in Cognitively Impaired Elderly: A Cross-Sectional Survey

  2013cited by this paper
• A Review: Treatment of Alzheimer’s Disease Discovered in Repurposed Agents

  2013cited by this paper
• Genome-wide Association Studies in Alzheimer’s Disease: A Review

  2013cited by this paper
• The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease.

  2013cited by this paper
• Sunlight and Vitamin D

  2013cited by this paper
• Microglia actions in Alzheimer’s disease

  2013cited by this paper
• Central administration of angiotensin IV rapidly enhances novel object recognition among mice.

  2013cited by this paper
• Trends in Diet and Alzheimer's Disease During the Nutrition Transition in Japan and Developing Countries

  2013cited by this paper
• Impact of Vitamin D on Amyloid Precursor Protein Processing and Amyloid-β Peptide Degradation in Alzheimer's Disease

  2013cited by this paper
• Deciphering the mechanism underlying late-onset Alzheimer disease

  2013cited by this paper
• Blood pro‐inflammatory cytokines in Alzheimer's disease in relation to the use of acetylcholinesterase inhibitors

  2013cited by this paper
• APOE e4 polymorphism in young adults is associated with improved attention and indexed by distinct neural signatures

  2013cited by this paper
• 25-Hydroxyvitamin D Levels and the Risk of Stroke: A Prospective Study and Meta-analysis

  2012cited by this paper
• Factors affecting independence in eating among elderly with Alzheimer's disease

  2012cited by this paper
• Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-β cascade.

  2012cited by this paper
• Mitochondrial Dysfunction—A Pharmacological Target in Alzheimer's Disease

  2012cited by this paper
• Swimming as a Positive Moderator of Cognitive Aging: A Cross-Sectional Study with a Multitask Approach

  2012cited by this paper
• Cognitive stimulation to improve cognitive functioning in people with dementia.

  2012cited by this paper
• Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

  2012cited by this paper
• Design, synthesis, and evaluation of resveratrol derivatives as Aß(₁-₄₂) aggregation inhibitors, antioxidants, and neuroprotective agents.

  2012cited by this paper
• Cognitive reserve in ageing and Alzheimer's disease.

  2012cited by this paper
• Socio-economic disadvantage and body mass over the life course in women and men: results from the Northern Swedish Cohort.

  2012cited by this paper
• The role of persistent and incident major depression on rate of cognitive deterioration in newly diagnosed Alzheimer's disease patients.

  2012cited by this paper
• Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.

  2012cited by this paper
• Effect of Selective Serotonin Reuptake Inhibitors in Alzheimer’s Disease with Comorbid Depression

  2012cited by this paper
• Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer’s disease in daily practice

  2012cited by this paper
• Higher vitamin D dietary intake is associated with lower risk of alzheimer's disease: a 7-year follow-up.

  2012cited by this paper
• Effect of Homocysteine Lowering Treatment on Cognitive Function: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2012cited by this paper
• Serum fatty-acid composition and the risk of Alzheimer’s disease: a longitudinal population-based study

  2012cited by this paper
• Metabolic-Cognitive Syndrome: Metabolic Approach for the Management of Alzheimer's Disease Risk

  2012cited by this paper
• Cardiovascular Risk Factors Promote Brain Hypoperfusion Leading to Cognitive Decline and Dementia

  2012cited by this paper
• Blockade of pro-cognitive effects of angiotensin IV and physostigmine in mice by oxytocin antagonism.

  2012cited by this paper
• Midlife Blood Pressure, Plasma &bgr;-Amyloid, and the Risk for Alzheimer Disease: The Honolulu Asia Aging Study

  2012cited by this paper
• Psychosis of Alzheimer disease: prevalence, incidence, persistence, risk factors, and mortality.

  2012cited by this paper
• Metabolic syndrome, mild cognitive impairment and Alzheimer's disease--the emerging role of systemic low-grade inflammation and adiposity.

  2012cited by this paper
• Blood Pressure J-Curve: Current Concepts

  2012cited by this paper
• Optimised Anaesthesia to Reduce Post Operative Cognitive Decline (POCD) in Older Patients Undergoing Elective Surgery, a Randomised Controlled Trial

  2012cited by this paper

• Licochalcone A as Novel Multitarget Inhibitors via AChE, BuChE, and Synapsin III for Therapeutic Intervention Against Alzheimer’s Disease: Computer‐Aided Drug Design

  2026cites this paper
• Antibody-based nanoparticles in Alzheimer's disease: Innovations in diagnosis and therapy.

  2026cites this paper
• The Role of Phytochemicals as Nutraceuticals in the Therapy of Cognitive Impairment: A Comprehensive Review

  2025cites this paper
• Bayesian interval estimation for predictive values from continuous diagnostic tests in case-control studies

  2025cites this paper
• Relating hippocampal subfield microstructure to delayed verbal memory in cognitively intact individuals at genetic risk for developing Alzheimer's disease.

  2025cites this paper
• LEAD: An EEG Foundation Model for Alzheimer's Disease Detection

  2025cites this paper
• Neighborhood environment associations with cognitive function and structural brain measures in older African Americans

  2025cites this paper
• Knowledge and Beliefs About Medical and Non‐Medical Interventions to Control Alzheimer’s Disease Among Latinos in New York City

  2025cites this paper
• Delirium management in perioperative geriatric services: a narrative review of non-pharmaceutical strategies

  2024cites this paper
• Explainable machine learning for predicting conversion to neurological disease: Results from 52,939 medical records

  2024cites this paper
• Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer’s Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study

  2024cites this paper
• Case Reports in the Integration of Technology with Cognitive Rehabilitation for Individuals with Memory Concerns and Their Care Partners

  2024cites this paper
• Immunotherapy in Alzheimer’s Disease: Current Status and Future Directions

  2024cites this paper
• Nilotinib as a Prospective Treatment for Alzheimer’s Disease: Effect on Proteins Involved in Neurodegeneration and Neuronal Homeostasis

  2024cites this paper
• Modeling Alzheimer's Disease using Cerebral Organoids: Current Challenges and Prospects

  2024cites this paper
• Dynamic and concordance-assisted learning for risk stratification with application to Alzheimer's disease.

  2024cites this paper
• ADformer: A Multi-Granularity Spatial-Temporal Transformer for EEG-Based Alzheimer Detection

  2024cites this paper
• Physical function is associated with cognitive status, brain amyloid‐beta deposition, and blood biomarkers in Chinese Han population

  2024cites this paper
• Detection of Alzheimer's Disease using MRI scans based on Inertia Tensor and Machine Learning

  2023cites this paper
• A new accuracy metric under three classes when subclasses are involved and its confidence interval estimation

  2023cites this paper
• Neuroprotection in metabolic syndrome by environmental enrichment. A lifespan perspective

  2023cites this paper
• The Beneficial Role of Photobiomodulation in Neurodegenerative Diseases

  2023cites this paper
• Mild Cognitive Impairment in Relation to Alzheimer’s Disease: An Investigation of Principles, Classifications, Ethics, and Problems

  2023cites this paper
• Cerebrospinal Fluid Diagnostics of Alzheimer’s Disease in Patients with Idiopathic Normal Pressure Hydrocephalus

  2023cites this paper
• Importance for humans of recently discovered protein compounds – yolkin and yolk glycopeptide 40, present in the plasma of hen egg yolk

  2023cites this paper
• Amyloid-beta aggregation implicates multiple pathways in Alzheimer’s disease: Understanding the mechanisms

  2023cites this paper
• Amyloid precursor protein in Alzheimer's disease.

  2023cites this paper
• miRNAs and Alzheimer’s Disease: Exploring the Role of Inflammation and Vitamin E in an Old-Age Population

  2023cites this paper
• Advances on Therapeutic Strategies for Alzheimer’s Disease: From Medicinal Plant to Nanotechnology

  2022cites this paper
• Photobiomodulation for Hypertension and Alzheimer’s Disease

  2022cites this paper
• Olfactory, Auditory, and Vestibular Performance: Multisensory Impairment Is Significantly Associated With Incident Cognitive Impairment

  2022cites this paper
• Retraction: Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection

  2022cites this paper
• Lights at night: does photobiomodulation improve sleep?

  2022influential citation
• HUZUREVİ MENÜLERİNİN BESİN ÖGESİ ÖRÜNTÜ PROFİLİ VE MIND DİYETİNE UYUMUNUN DEĞERLENDİRİLMESİ

  2021cites this paper
• Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice.

  2021cites this paper
• Cognitive Decline in Alzheimer’s Disease Is Not Associated with APOE

  2021cites this paper
• Polyamine biomarkers as indicators of human disease

  2021cites this paper
• Dietary phytochemicals that influence gut microbiota: Roles and actions as anti-Alzheimer agents

  2021cites this paper
• Correlation of [18F]florbetaben textural features and age of onset of Alzheimer’s disease: a principal components analysis approach

  2021cites this paper
• The Impact of COVID-19 Quarantine on Patients With Dementia and Family Caregivers: A Nation-Wide Survey

  2021cites this paper
• Linguistic Parameters of Spontaneous Speech for identifying Mild Cognitive Impairment and Alzheimer’s Disease Linguistic Parameters of Spontaneous Speech for identifying Mild Cognitive Impairment and Alzheimer’s Disease

  2021cites this paper
• Linguistic Parameters of Spontaneous Speech for Identifying Mild Cognitive Impairment and Alzheimer Disease

  2021cites this paper
• Improved Mood Boosts Memory Training Gains in Older Adults With Subjective Memory Complaints: A Randomized Controlled Trial

  2021cites this paper
• BMP4 overexpression induces the upregulation of APP/Tau and memory deficits in Alzheimer’s disease

  2020cites this paper
• Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing

  2020influential citation
• Can Visual Art Therapy Be Implemented With Illiterate Older Adults With Mild Cognitive Impairment? A Pilot Mixed-Method Randomized Controlled Trial

  2020cites this paper
• Non‐pharmacological management of Alzheimer's disease: A qualitative study in Mauritius

  2020cites this paper
• Person-Centered Care Education for Caregivers of Patients With Dementia in Long-Term Care Settings

  2020cites this paper
• Role of Mind Diet in Preventing Dementia and Alzheimers Disease

  2020cites this paper
• Neuropsychological outcome of cognitive training in mild to moderate dementia: A randomized controlled trial

  2020cites this paper
• Long-Term Intake of Dietary Carotenoids Is Positively Associated with Late-Life Subjective Cognitive Function in a Prospective Study in US Women.

  2020cites this paper
• Environmental and Cognitive Enrichment in Childhood as Protective Factors in the Adult and Aging Brain

  2020influential citation
• Sugarcane (Saccharum officinarum L.) Top Extract Ameliorates Cognitive Decline in Senescence Model SAMP8 Mice: Modulation of Neural Development and Energy Metabolism

  2020cites this paper
• Relationship between thyroid dysfunction and dementia

  2020cites this paper
• Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease

  2020cites this paper
• Anacardic Acid Complexes as Possible Agents Against Alzheimer’s Disease Through Their Antioxidant, In vitro, and In silico Anticholinesterase and Ansiolic Actions

  2020cites this paper
• Role of nutraceuticals in cognition during aging and related disorders.

  2020cites this paper
• Envisioning the crosstalk between environmental enrichment and epilepsy: A novel perspective.

  2020cites this paper
• Деменции позднего возраста: факторы, ассоциированные со скоростью прогрессирования деменции. Часть 2

  2020cites this paper
• Photobiomodulation as a treatment for neurodegenerative disorders: current and future trends

  2019cites this paper
• Fructooligosaccharides Ameliorating Cognitive Deficits and Neurodegeneration in APP/PS1 Transgenic Mice through Modulating Gut Microbiota.

  2019cites this paper
• Aging, Physical Exercise and Cognitive Dysfunctions

  2019cites this paper
• A review on complementary and alternative treatments for dementia

  2019cites this paper
• Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment

  2019cites this paper
• Nutrients in the Prevention of Alzheimer's Disease

  2019cites this paper
• A socio-history and genealogy of dementia thought and conceptualisation in Western society

  2019cites this paper
• Identifying Mild Cognitive Impairment and mild Alzheimer's disease based on spontaneous speech using ASR and linguistic features

  2019cites this paper
• Assessing Alzheimer's Disease from Speech Using the i-vector Approach

  2019cites this paper
• Major Neurocognitive Disorder with Behavioral Disturbance (Behavioral and Psychological Symptoms of Dementia—BPSD)

  2019cites this paper
• Dementia in Down syndrome: unique insights for Alzheimer disease research

  2019cites this paper
• Validity and Reliability of a 5-minute Web-Camera Based Eye Tracking Test to Assess Visual Memory and Cognition

  2019cites this paper
• Effects of Physical Exercise on the P300 of Elderly With Alzheimer's Disease.

  2018cites this paper
• Systematic review of behaviour change techniques to promote participation in physical activity among people with dementia

  2018cites this paper
• The Effects of Exercise on the Cognitive Function of Patients with Alzheimer’s Disease

  2018cites this paper
• The Benefits of Temu Mangga (Curcuma Mangga Val) in Cognitive Functions of Elderly

  2018cites this paper
• Economic Evaluation of Nonpharmacological Interventions for Dementia Patients and their Caregivers - A Systematic Literature Review

  2018cites this paper
• Situated Prevention: Framing the “New Dementia”

  2018cites this paper
• The Enhanced Interactive Physical and Cognitive Exercise System (iPACESTM v2.0): Pilot Clinical Trial of an In-Home iPad-Based Neuro-Exergame for Mild Cognitive Impairment (MCI)

  2018cites this paper
• Exercise-induced adaptations in patients with Alzheimer’s disease: the role of circadian scheduling

  2018cites this paper
• Effects of Cognitive Training on Cognition and Quality of Life of Older Persons with Dementia

  2018cites this paper
• Effects of Functional-Task Training on Older Adults With Alzheimer's Disease.

  2018cites this paper
• Neighborhood built environment and cognition in non-demented older adults: The Multi-Ethnic Study of Atherosclerosis.

  2018cites this paper
• Identifying Patterns in Signs and Symptoms Preceding the Clinical Diagnosis of Alzheimer's Disease: Retrospective Medical Record Review Study and a Nested Case-control Design.

  2018cites this paper
• [Role of Mediterranean diet on the prevention of Alzheimer disease].

  2017cites this paper
• Association of long-term adherence to the mind diet with cognitive function and cognitive decline in American women

  2017cites this paper
• Neighborhood Environment and Cognition in Older Adults: A Systematic Review.

  2017cites this paper
• The Dietary Approaches to Stop Hypertension Diet, Cognitive Function, and Cognitive Decline in American Older Women.

  2017cites this paper
• Neonatal alcohol exposure reduces number of parvalbumin-positive interneurons in the medial prefrontal cortex and impairs passive avoidance acquisition in mice deficits not rescued from exercise.

  2017cites this paper
• Nutrition and AGE-ing: Focusing on Alzheimer's Disease

  2017cites this paper
• Immunopathology of the Nervous System

  2017cites this paper
• Dieta mediterránea y sus efectos benéficos en la prevención de la enfermedad de Alzheimer

  2017cites this paper
• Feasibility and baseline findings of a Finnish cognitive training (FINCOG) intervention in a randomised controlled trial among community-dwelling persons with dementia

  2017cites this paper
• Assessment of the pharmacokinetic profile of novel s‐triazine derivatives and their potential use in treatment of Alzheimer's disease

  2017cites this paper
• Neighborhood Built Environment Characteristics and Cognition in Non-demented Older Adults

  2017cites this paper
• Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease

  2016cites this paper
• Amelioration of Symptoms and Biomarkers of Alzheimers Disease by Physical Exercise

  2016cites this paper
• Psychiatric and Medical Comorbidity in the Primary Care Geriatric Patient—An Update

  2016cites this paper
• Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and 18F-FDG PET Study

  2016cites this paper
• Interleukin-18 −137 G/C and −607 C/A polymorphisms and Alzheimer’s disease risk: a meta-analysis

  2016cites this paper
• Efficacy of three nonpharmacological interventions for Alzheimer's disease

  2016cites this paper